Bridging areas of injury in the spinal cord

Mary B Bunge

Research output: Contribution to journalArticle

153 Citations (Scopus)

Abstract

There is a devastating loss of function when substantial numbers of axons are interrupted by injury to the spinal cord. This loss may be eventually reversed by providing bridging prostheses that will enable axons to regrow across the injury site and enter the spinal cord beyond. This review addresses the bridging strategies that are being developed in a number of spinal cord lesion models: complete and partial transection and cavities arising from contusion. Bridges containing peripheral nerve, Schwann cells, olfactory ensheathing glia, fetal tissue, stem cells/neuronal precursor cells, and macrophages are being evaluated as is the administration of neurotrophic factors, administered by infusion or secreted by genetically engineered cells. Biomaterials may be an important factor in developing successful strategies. Due to the complexity of the sequelae following spinal cord injury, no one strategy will be effective. The compelling question today is: What combinations of the strategies discussed, or new ones, along with an initial neuroprotective treatment, will substantially improve outcome after spinal cord injury?

Original languageEnglish
Pages (from-to)325-339
Number of pages15
JournalNeuroscientist
Volume7
Issue number4
StatePublished - Aug 1 2001

Fingerprint

Spinal Cord Injuries
Axons
Spinal Cord
Fetal Stem Cells
Contusions
Schwann Cells
Nerve Growth Factors
Biocompatible Materials
Peripheral Nerves
Neuroglia
Prostheses and Implants
Fetus
Macrophages
Neurons
Wounds and Injuries

Keywords

  • Cellular bridges
  • CNS injury
  • CNS regeneration
  • Neurotrophins
  • Transplantation

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Bunge, M. B. (2001). Bridging areas of injury in the spinal cord. Neuroscientist, 7(4), 325-339.

Bridging areas of injury in the spinal cord. / Bunge, Mary B.

In: Neuroscientist, Vol. 7, No. 4, 01.08.2001, p. 325-339.

Research output: Contribution to journalArticle

Bunge, MB 2001, 'Bridging areas of injury in the spinal cord', Neuroscientist, vol. 7, no. 4, pp. 325-339.
Bunge MB. Bridging areas of injury in the spinal cord. Neuroscientist. 2001 Aug 1;7(4):325-339.
Bunge, Mary B. / Bridging areas of injury in the spinal cord. In: Neuroscientist. 2001 ; Vol. 7, No. 4. pp. 325-339.
@article{c2a4f2265d924b4fb9fd833b8a3a412e,
title = "Bridging areas of injury in the spinal cord",
abstract = "There is a devastating loss of function when substantial numbers of axons are interrupted by injury to the spinal cord. This loss may be eventually reversed by providing bridging prostheses that will enable axons to regrow across the injury site and enter the spinal cord beyond. This review addresses the bridging strategies that are being developed in a number of spinal cord lesion models: complete and partial transection and cavities arising from contusion. Bridges containing peripheral nerve, Schwann cells, olfactory ensheathing glia, fetal tissue, stem cells/neuronal precursor cells, and macrophages are being evaluated as is the administration of neurotrophic factors, administered by infusion or secreted by genetically engineered cells. Biomaterials may be an important factor in developing successful strategies. Due to the complexity of the sequelae following spinal cord injury, no one strategy will be effective. The compelling question today is: What combinations of the strategies discussed, or new ones, along with an initial neuroprotective treatment, will substantially improve outcome after spinal cord injury?",
keywords = "Cellular bridges, CNS injury, CNS regeneration, Neurotrophins, Transplantation",
author = "Bunge, {Mary B}",
year = "2001",
month = "8",
day = "1",
language = "English",
volume = "7",
pages = "325--339",
journal = "Neuroscientist",
issn = "1073-8584",
publisher = "SAGE Publications Inc.",
number = "4",

}

TY - JOUR

T1 - Bridging areas of injury in the spinal cord

AU - Bunge, Mary B

PY - 2001/8/1

Y1 - 2001/8/1

N2 - There is a devastating loss of function when substantial numbers of axons are interrupted by injury to the spinal cord. This loss may be eventually reversed by providing bridging prostheses that will enable axons to regrow across the injury site and enter the spinal cord beyond. This review addresses the bridging strategies that are being developed in a number of spinal cord lesion models: complete and partial transection and cavities arising from contusion. Bridges containing peripheral nerve, Schwann cells, olfactory ensheathing glia, fetal tissue, stem cells/neuronal precursor cells, and macrophages are being evaluated as is the administration of neurotrophic factors, administered by infusion or secreted by genetically engineered cells. Biomaterials may be an important factor in developing successful strategies. Due to the complexity of the sequelae following spinal cord injury, no one strategy will be effective. The compelling question today is: What combinations of the strategies discussed, or new ones, along with an initial neuroprotective treatment, will substantially improve outcome after spinal cord injury?

AB - There is a devastating loss of function when substantial numbers of axons are interrupted by injury to the spinal cord. This loss may be eventually reversed by providing bridging prostheses that will enable axons to regrow across the injury site and enter the spinal cord beyond. This review addresses the bridging strategies that are being developed in a number of spinal cord lesion models: complete and partial transection and cavities arising from contusion. Bridges containing peripheral nerve, Schwann cells, olfactory ensheathing glia, fetal tissue, stem cells/neuronal precursor cells, and macrophages are being evaluated as is the administration of neurotrophic factors, administered by infusion or secreted by genetically engineered cells. Biomaterials may be an important factor in developing successful strategies. Due to the complexity of the sequelae following spinal cord injury, no one strategy will be effective. The compelling question today is: What combinations of the strategies discussed, or new ones, along with an initial neuroprotective treatment, will substantially improve outcome after spinal cord injury?

KW - Cellular bridges

KW - CNS injury

KW - CNS regeneration

KW - Neurotrophins

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=0034911949&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034911949&partnerID=8YFLogxK

M3 - Article

VL - 7

SP - 325

EP - 339

JO - Neuroscientist

JF - Neuroscientist

SN - 1073-8584

IS - 4

ER -